A detailed history of Alpine Global Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Alpine Global Management, LLC holds 293,706 shares of LAB stock, worth $563,915. This represents 0.12% of its overall portfolio holdings.

Number of Shares
293,706
Holding current value
$563,915
% of portfolio
0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.92 $484,614 - $857,621
293,706 New
293,706 $519,000
Q3 2022

Nov 14, 2022

BUY
$1.1 - $2.06 $14,822 - $27,758
13,475 New
13,475 $15,000
Q1 2022

May 13, 2022

SELL
$2.8 - $3.96 $33,202 - $46,957
-11,858 Reduced 46.81%
13,475 $48,000
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $91,958 - $155,291
25,333 New
25,333 $99,000
Q1 2021

May 13, 2021

SELL
$3.94 - $7.09 $82,669 - $148,762
-20,982 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$5.45 - $8.65 $114,351 - $181,494
20,982 New
20,982 $126,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $151M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.